Skip to content

Boston Scientific BSX Preferred Stock, Shares Issued

Preferred Stock, Shares Issued at other companies

Abbott logo
AbbottABT
Intuitive Surgical logo
Intuitive SurgicalISRG
ResMed logo
ResMedRMD
Cardinal Health logo
Cardinal HealthCAH
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$66.81B-37.5%
P/E18.8×-34.0×
P/S3.2×-2.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's preferred stock, shares issued.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's preferred stock, shares issued?
Boston Scientific (BSX) reported preferred stock, shares issued of 0 in Q1 2026.
What is the long-term trend for Boston Scientific's preferred stock, shares issued?
Over 5 years (2020 to 2025), Boston Scientific's preferred stock, shares issued has grown at a -100.0% compound annual growth rate (CAGR), from 10.1M to 0.